LIORESAL intrathécal sol inj 0.05 mg/ml amp 5 pce
7680525350182
CH-52535
M03BX01
01.12.0.
Reimbursement limitations:
LIORESAL
Spasticité résistante au traitement.
1 / 3
google
Details
- Product number
- 5253501
- CPT
- -
- Packaging group
- 5
- Unit
- Ampulle(n)
- Composition
- baclofenum 50 µg, natrii chloridum corresp. natrium 3.54 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Lioresal intrathecal 0,05 mg/1 mL, Ampullen
Ampullen
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.54 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 52535
- Drug name
- Lioresal intrathecal, Ampullen
- Galenic form
- LSIN
- ATC Code
- M03BX01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 25/08/1994
- Authorization expiration date
- 31/12/9999
- IT number
- 01.12.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LIORESAL intrathécal sol inj 0.05 mg/ml amp 5 pce
- Description (DE)
- LIORESAL intrathecal Inj Lös 0.05 mg/ml Amp 5 Stk
- Market launch
- 25/08/1994
- Narcotic (BTM)
- No